Med. Pro Praxi 2009; 6(6)

ORL a oftalmologie

Published: January 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
ORL a oftalmologie. Med. praxi. 2009;6(6):.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Kraus H, a kol. Kompendium očního lékařství. Dotisk. Praha: Grada, 1999.
    2. Kuchynka P, a kol. Oční lékařství. 1. vyd. Praha: Grada, 2007.
    3. ##
    4. Kanski JJ. Clinical Ophthalmology. A Synopsis. 2 Ev Ed. Elsevier Health Sciences (United Kingdom), 2009. Go to original source...
    5. Kuchyňka P, a kol. Oční lékařství. 1. vydání. Praha: Grada Publishing, a.s., 2007: 621-622.
    6. Gilchrist H. Australian family physician. 2009; 38(4): Management of chalazia in general practice. Dostupný z www.racgp. org.au. Cit. 2009-09-20.
    7. Mueller JB, McStay ChM. Ocular Infection And Inflamation. Emergency medicine Clinics of North America 2008; 26(1): 57-72. Dostupný z www.sciencedirect.com. Cit. 2009-09-20. Go to original source... Go to PubMed...
    8. Buttaravoli P. Minor Emergencies. 2nd Edition. Splinters to Fractues. 2007. page 85-86. Chapter 19: Hordeolum (Stye). Dostupný z www.sciencedirect.com. Cit. 2009-09-20. Go to original source...
    9. Yanoff M, Duker JS, Augsburger JJ. Ophthalmology. 2nd Edition. Mosby.
    10. ##
    11. Borovanská J, Baráková D, Ředinová M, Souček P. Maligní melanom cévnatky. Postgraduální medicína, 2002; 4(7): 792-798.
    12. Cihelková I, Souček P. Atlas makulárních chorob. Atlas of macular diseases. 1. vydání. Praha: Galén/Karolinum, 2005: 521 s.
    13. Cihelková I, Souček P, Šach J. Uveal melanoma in congenital ocular melanocytosis mimicking malignant transformation of the optic disc melanocytoma (A controlled case). Neuroendocrinology Letters. 2006; 27(6): 729-732. Go to PubMed...
    14. Souček P. Nitrooční tumory nemelanocytární. In: Baráková D (ed.). Oční tumory. Praha: Grada, 2002: 101-112.
    15. Souček P, Kuchynka P, Baráková D. Současné trendy v léčbě nádorů oka. In: Baráková D (ed.). Oční tumory. Praha: Grada, 2002: 113-126.
    16. Souček P, Cihelková I. Evaluation of subretinal fluid absorption by optical coherence tomography in circumscribed choroidal hemangioma after photodynamic therapy with verteporfin. Neuroendocrinology Letters, 2004; 25(1/2): 109-114. Go to PubMed...
    17. Souček P, Cihelková I. Photodynamic therapy with verteporfin in subfoveal amelanotic choroidal melanoma (A controlled case). Neuroendocrinology Letters, 2006; 27(1/2): 145-148. Go to PubMed...
    18. Souček P, Cihelková I. Comment on Donaldson MJ, et al. Primary treatment of choroidal amelanotic melanoma with photodynamic therapy. Clin Experiment Ophthalmol. 2006; 34: 721. Go to original source... Go to PubMed...
    19. Souček P, Cihelková I. Photodynamic therapy with verteporfin in subfoveal choroidal metastasis of breast carcinoma (A controlled case). Neuroendocrinology Letters, 2006; 27(6): 725-732. Go to PubMed...
    20. Souček P, Cihelková I, Krásný J. Nitrooční tumory. In: Kuchynka P (ed.). Oční lékařství. Praha: Grada, 2007: 479-500.
    21. Souček P, Kuchynka P. Využití digitálního zobrazovacího systému v oftalmologii. Lékařské listy, příloha Zdravotnických novin, 1999; 48(32): 6.
    22. Součková I, Souček P. Optická koherentní tomografie u benigních a maligních melanocytárních nádorů. Čes. a slov. Oftal., 2008; 64: 228-230.
    23. Šimonová G, Liščák R, Novotný J jr., Souček P, et al. Léčba choroidálních melanomů na Leksellově gama noži - výsledky. Radiační onkologie. 6(1): 19-25.
    24. ##
    25. Klein R, Klein BE, Moss SE, a kol. The Wisconsin Epidemiologic Study of Diabetic Retinopathy, IV: diabetic macular edema. Ophthalmology 1984; 91: 1464-1474. Go to original source... Go to PubMed...
    26. Klein R, Moss SE, Klein BE, Davis MD, DeMets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy, IX: The incidence of macular edema. Ophthalmology 1989: 96: 1501-1510. Go to original source... Go to PubMed...
    27. Strmeň P. Diabetická retinopatia. In: Ponťuch P, Strmeň P, Krahulec B, Vozár J. Diabetická nefropatia, retinopatia, neuropatia. Martin: Osveta, 1993: 61-95.
    28. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 1993; 329(14): 977-986. Go to original source... Go to PubMed...
    29. UKPDS Study Group. Intensive blood - glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study Group. (UKPDS). Lancet 1998; 352: 837-853. Go to original source...
    30. Sosna T, Bouček P, Fišer I. Diabetická retinopatie. Praha: J. Cendelín, 2001: 255 s.
    31. Early Treatment of Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Graefes Arch Clin Exp Ophthalmol 1985; 103: 1796-1806. Go to original source...
    32. Wilkinson ChP, Ferris III FL, Klein RE, a kol. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 2003: 110: 1677-1682. Go to original source... Go to PubMed...
    33. Olk RJ. Modified grid blue - green laser photocoagulation for diffuse diabetic macular edema. Ophthalmology 1986; 93: 938-950. Go to original source... Go to PubMed...
    34. Gandorfer A, Messmer E, Ulbig MW, Kampik A. resolution of diabetic macular edema after surgical removal of the posterior hyaloid and the inner limiting membrane. Retina 2000; 20: 123-133. Go to original source...
    35. Stolba U, Binder S, Gruber D, a kol. Vitrectomy for persistent diffuse diabetic macular edema. Am J Ophthalmol 2005; 140: 295-301. Go to original source... Go to PubMed...
    36. Nasrallah FP, Jalkh AE, Van Coppenrolle F, a kol. The role of the vitreous in diabetic macular edema. Ophthalmology 1988; 95: 1335-1339. Go to original source... Go to PubMed...
    37. Matsunaga N, Ozeki H, Hirabayashi Y. Histopathologic evaluation of the internal limiting membrane surgically excised from eyes with diabetic maculopathy. Retina 2005; 25: 311-316. Go to original source... Go to PubMed...
    38. Machemer R, Sugita G, Tano Y. Treatment of intraocular proliferations with intravitreal steroids. Trans Am Ophthalmol Soc 1979; 77: 171-180. Go to PubMed...
    39. Chieh JJ, Roth DB, Liu M, a kol. Intravitreal triamcinolone acetonide for diabetic macular edema. Retina 2005; 25: 828-834. Go to original source... Go to PubMed...
    40. Lam DS, Chan CK, Mohamed S, a kol. A prospective randomised trial of different doses of intravitreal triamcinolone for diabetic macular oedema. Br J Ophthalmol 2007; 91: 199-203. Go to original source... Go to PubMed...
    41. Peyman GA, Cheema R, Conway MD, a kol. Triamcinolon acetonide as an aid to visualization of the vitreous and the posterior hyaloid during pars plana vitrectomy. Retina 2000; 20: 554-555. Go to original source... Go to PubMed...
    42. Sharma A, Kuppermann BD. New and In-development treatments for diabetic macular edema. Retinal physician. July/August 2008; 20-30.
    43. Haritoglu C, Kook D, Neubauer A, a kol. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema. Retina 2006; 26: 999-1005. Go to original source... Go to PubMed...
    44. Cunningham ET, Jr, Adamis AP, Altaweel M, a kol. A phase II randomized double - masked trial of pegaptanib, an antivascular endothelial growth factor aptamer, for diabetic macular edema. Ophthalmology 2005; 112: 1747-1757. Go to original source... Go to PubMed...
    45. Chun DW, Heier JS, Topping TM, a kol. A pilot study of multiple intravitreal injections of ranibizumab in patients with center-involving clinically significant diabetic macular edema. Ophthalmology 2006; 113: 1706-1712. Go to original source... Go to PubMed...
    46. ##
    47. Hamra ST. Repositioning of the orbicularis oculi muscle in composite rhytidectomy. Plast Recontr Surg. 1992; 90: 14. Go to original source... Go to PubMed...
    48. Aston SJ, Beasley RW (ed.). Grabb and Smith's Plastic Surgery. Fifth Edition. Philadelphia: Lippincott-Raven, 1997: 611-612.
    49. Pintér L. Estetická chirurgie. Hradec Králové, RNDr. František Skopec, CSc. Nucleus HK, 2007: 45-48.
    50. Kuchynka P, et al. Oční lékařství. Praha: Grada Publishing, a.s., 2007: 636.
    51. Heilmann K, Paton D (ed.). Atlas of ophthamic surgery. Stuttgart: Georg Thieme Verlag, 1985.
    52. ##
    53. Fait T, Vráblík M, Češka R, et al. Preventivní medicína. Praha: Maxdorf-Jessenius, 2008: 377-399 s.
    54. Komínek P, Chrobok V, Astl J. Záněty hltanu. Havlíčkův Brod: Tobiáš, Edice Medicína hlavy a krku, 2005: 322 s.
    55. Lischkeová B, Klimák P, Astl J, et al. Indikace k tonsilektomii. Otorinolaryng. a Foniatr. 2000; 49(1): 22-25.
    56. Tan JS. Experts guide to infections diseases. Philadelphia: American College of Physicans, 2002: 846 s.
    57. ##
    58. Fokkens W, Lund VJ, Mullol J, et al. European Position Paper on Rhinosinusitis and Nasal Polyps. Rhinology 2007; 20(Suppl): 1-136. Go to PubMed...
    59. Bachert C, Hoermann R, Moesges R. An update on the diagnosis and treatment of sinusitis and nasal polyposis. Allergy 2003; 58: 176-191. Go to original source... Go to PubMed...
    60. Kaliner M. Treatment of sinusitis in the next millenium. Allergy Astma Proc 1998; 19: 181-184. Go to original source... Go to PubMed...
    61. Inuma T, Hirota Z, Kase Z. Radio-opacity of the paranasal sinuses. Conventional views and CT. Rhinology 1994; 32: 134-138. Go to PubMed...
    62. McAlister WH, Lusk R, Munz HR. Comparison of plain radiographs and coronal CT scane in infants and children with recurrent sinusitis. Am J Roentgenol 1989; 153: 1259-1264. Go to original source... Go to PubMed...
    63. Urbášková P. Možnosti omezení znepokojivých trendů antibiotické rezistence bakterií v České republice. Practicus 2004; 3: 30-32.
    64. Stringer SP, Mancuso AA, Avino AJ. Effect of a topical vasoconstrictor on computed tomography of paranasal sinus disease. Laryngoscope 1993; 103: 6-9. Go to original source... Go to PubMed...
    65. Meltzer EO, Chamrous BL, Buse WW, et al. Added relief in the treatment of of acute recurrent sinusitis with adjunctive mometason furoate nasal spray. The Nasonex Sinusitis group. J Allergy Clin Immunol 2000; 106: 630-637. Go to original source... Go to PubMed...
    66. Meltzer EO, Orgel HA, Backhaus JW, et al. Intranasal flunisolide spray as an adjunct to oral antibiotic therapy for sinusitis. J Allergy Clin Immunol 19936; 92: 812-823. Go to original source... Go to PubMed...
    67. Nayak AS, Settipane GA, Pedinoff, et al. Effective dose range of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Ann Alergy Asthma Immunol 2002; 89: 271-278. Go to original source... Go to PubMed...
    68. Meltzer EO, Bachert C, Staudinger H. Treating acute rhinosinusitis: Comparing efficacy and safety of mometasone furoat nasal spray, amoxicilin and placebo. J Allergy Clin Imunol 2005; 116: 1289-1295. Go to original source... Go to PubMed...
    69. Johansson L, Akerlund A, Holmberg K, et al. Prevalence of nasal polyps in adults: the Skovde population-based study. Ann Otol Rhinol Laryngo 2003; 112: 625-629. Go to original source... Go to PubMed...
    70. Hedmann J, Kaprio J, Poussa T, et al. Prevalence of astma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study. Int J. Epidemiol 1999; 28: 717-722. Go to original source... Go to PubMed...
    71. Rugina M, Serrano E, Klossek JM. Epidemiological and clinical aspects of nasal polyposis in France, the ORLI group experience. Rhinology 2002; 20: 75-79.
    72. Lang JJ, Curra AJ, Patil N, et al. Intracranial complications of acute frontal sinusitis. Clin Otolaryngol 2001; 26: 452-457. Go to original source... Go to PubMed...

    Return to the content


    Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.